Study on Traditional Chinese Medicine Syndrome Types in NPC
Clinical Medicine and Pharmacology · 31.05.2026 · 3 (3) · 13-20
DOI: 10.70731/n1rkpc59 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine and Pharmacology, online erschienen am 31.05.2026. Verfasst von Yao Wu und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As one of head and neck tumors, nasopharyngeal carcinoma (NPC) occurs most frequently in the south of China, especially in Hunan, Guangzhou and other places, causing serious harm to people's life and health. NPC patient is mainly treated with radiotherapy in clinic, but most of them have serious side effects. At present, traditional Chinese medicine (TCM) combined with chemoradiotherapy in the treatment of NPC patient has been focused on by Chinese and Western clinicians. Although TCM syndrome differentiation has significant advantages in the treatment of nasopharyngeal cancer, the relevant syndrome type standards for TCM syndrome differentiation guidance are still not unified. Therefore, this paper summarized the clinical experience, clinical data analysis and experimental research of TCM scholars in recent years, discussed the role and influence of TCM syndrome differentiation on the treatment of NPC. It provides some guidance for the standardization of TCM syndrome differentiation of NPC patients.
Zitieren
APA
Wu, Y., Chen, L., & Tang, F. (2026). Study on Traditional Chinese Medicine Syndrome Types in NPC. Clinical Medicine and Pharmacology, 3(3), 13-20. https://doi.org/10.70731/n1rkpc59
Vancouver
Wu Y, Chen L, Tang F. Study on Traditional Chinese Medicine Syndrome Types in NPC. Clinical Medicine and Pharmacology. 2026;3(3):13-20. doi:10.70731/n1rkpc59
BibTeX
@article{Wu2026,
author = {Wu, Yao and Chen, Lin and Tang, Faqing},
title = {Study on Traditional Chinese Medicine Syndrome Types in NPC},
journal = {Clinical Medicine and Pharmacology},
year = {2026},
volume = {3},
number = {3},
pages = {13--20},
doi = {10.70731/n1rkpc59}
}
EUVIMED